RxSight (RXST) Other Operating Expenses (2020)

RxSight (RXST) posted Other Operating Expenses of $7000.0 for Q4 2020.

RxSight (RXST) Other Operating Expenses (2020) Analysis & Trends

RxSight's Other Operating Expenses history runs 1 years deep, the most recent figure standing at $7000.0 for Q4 2020.

Quarterly Other Operating Expenses changed N/A year-over-year to $7000.0 in Q4 2020, while the trailing twelve-month figure through Sep 2021 was $7000.0 (changed N/A YoY) and the FY2020 annual result came in at $7000.0, changed N/A from the prior year.
Other Operating Expenses was $7000.0 for Q4 2020 at RxSight.
Across five years, Other Operating Expenses topped out at $7000.0 in Q4 2020 and bottomed at $7000.0 in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	RxSight	221.81 Mn	-196.39 Mn	23.50 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2020	7,000.00